Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.04
-0.34 (-1.85%)
At close: Oct 29, 2025, 4:00 PM EDT
17.71
-0.33 (-1.83%)
After-hours: Oct 29, 2025, 6:42 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Pharmaceutical
1.41M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
-58.15%
Log In
Log In
Log In
Log In
Upgrade
License and Other
516.00K
Log In
Log In
Log In
Log In
Upgrade
License and Other Growth
-96.49%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
United States
1.92M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-89.34%
Log In
Log In
Log In
Log In
Upgrade